A molecular mechanism mediating clozapine-enhanced sensorimotor gating

Area of Science:

• Neuroscience
• Psychopharmacology
• Molecular Biology

Background:

• Atypical antipsychotics, like clozapine, affect sensorimotor gating via prepulse inhibition (PPI).
• The adaptor protein p11 is implicated in anxiety, depression, and G-protein-coupled receptor function.
• The role of p11 in antipsychotic modulation of PPI remains unexplored.

Purpose of the Study:

• To investigate the role of p11 in clozapine's ability to enhance sensorimotor gating (PPI).
• To examine how p11 deficiency affects responses to clozapine, risperidone, and haloperidol.
• To explore the impact of p11 on brain structure and function, particularly hippocampal connectivity.

Main Methods:

• Tested wild-type and p11 knockout (KO) mice in PPI assays with various antipsychotics.
• Administered haloperidol, risperidone, and clozapine to assess behavioral responses.
• Conducted structural and functional brain imaging to analyze neuroanatomical differences.

Main Results:

• p11 knockout mice showed no PPI enhancement with risperidone or clozapine.
• Contrary to hypotheses, p11-KO mice did not exhibit heightened startle or clozapine sensitivity.
• p11-KO mice displayed altered brain volumes, reduced hippocampal connectivity, and blunted clozapine effects in the CA1 region.

Conclusions:

• p11 plays a novel role in modulating clozapine's effects on sensorimotor gating.
• p11 influences clozapine-induced changes in hippocampal connectivity.
• These findings offer new insights into the functional pathways of clozapine and p11.